Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage
Por:
Reyes-Pardo H., Bautista R., Vargas-Robles H., Rios A., Sánchez D., Escalante B.
Publicada:
1 ene 2019
Categoría:
Nephrology
Resumen:
Background: Renal proximal tubular sodium and glucose reabsorption are regulated by the sodium-glucose cotransporter (SGLT2). Changes in this transporter can play a role in hyperglycaemia and reactive oxygen species (ROS) production. We demonstrated increased glucose absorption in proximal tubule membrane vesicles and increased expression of SGLT2 in hypertensive rats. Here we investigated Angiotensin II (Ang II) -dependent SGLT2 expression induction and the role of SGLT2 induction in the development of Ang II-dependent kidney damage. The aim of this study was to determine whether SGLT2 induction by Ang II is associated with Ang II-dependent kidney damage. We propose the following objectives a) to demonstrate that Ang II induces SGLT2 expression and b) to demonstrate that prevention of SGLT2 expression and activity prevent Ang II-induced kidney damage. Methods: We used chronic Ang II infusion as a model of kidney damage in male Wistar rats and evaluated systolic blood pressure by telemetric methods. SGLT2 mRNA and protein expression were evaluated by PCR and immunoblotting. SGLT2 activity was evaluated in brush border membrane vesicles by measuring glucose uptake. ROS production was measured by confocal microscopy. The glomerular filtration rate (GFR) was evaluated by the inulin excretion method, and urinary protein excretion was evaluated by the Bradford method. Biological parameter evaluations were performed, after two weeks of infusion of Ang II. We compared the effects of Angiotensin II (AT1) receptor blockade by Losartan and SGLT2 inhibition by Empagliflozin both as monotherapy treatments and in combination on the development of kidney damage. Results: Chronic Ang II infusion led to a blood pressure elevation and increased SGLT2 mRNA expression and activity as well as kidney damage, as reflected by increased ROS production, decreased GFR and increased urinary protein excretion. AT1 receptor blockade prevented all these changes. By contrast, SGLT2 inhibition did not affect blood pressure and had a small effect on kidney damage. However, the combination of both drugs resulted in the potentiation of the effects observed by AT1 receptor blockade alone. Conclusions: We suggest that Ang II-dependent increased SGLT2 induction is one mechanism by which Ang II induces kidney damage. © 2019 The Author(s).
Filiaciones:
Reyes-Pardo H.:
Unidad Monterrey, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Vía del Conocimiento 201, Apodaca, Nuevo-León, 66600, Mexico
Bautista R.:
Department of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
Vargas-Robles H.:
Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Mexico City, Mexico
Rios A.:
Unidad Monterrey, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Vía del Conocimiento 201, Apodaca, Nuevo-León, 66600, Mexico
Sánchez D.:
Unidad Monterrey, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Vía del Conocimiento 201, Apodaca, Nuevo-León, 66600, Mexico
Escalante B.:
Unidad Monterrey, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Vía del Conocimiento 201, Apodaca, Nuevo-León, 66600, Mexico
Basic Science Department, Monterrey University, Morones Prieto 4500, San-Pedro Garza-Garcia Nuevo-León N.L., 66238, Mexico
|